Best SellerWeight Loss & Metabolic
GLP-1 receptor agonist
Semaglutide is a GLP-1 receptor agonist studied extensively within glucose-regulation and appetite-signalling research. A cornerstone metabolic research compound.
Dosage
Research Focus
This product is intended strictly for laboratory and research purposes only. Not for human or animal consumption. Not evaluated by the FDA. You must be 21 years or older to purchase.